Ovarian reserve—broadly understood as the remaining quantity and quality of a woman’s eggs—is one of the most discussed topics in fertility after 35. The term appears frequently in fertility consultations, online forums, and media coverage of reproductive health, often in ways that generate more anxiety than clarity. Understanding what ovarian reserve actually measures, how it is assessed, and what the results do and don’t mean can provide a more grounded foundation for fertility planning.
Every woman is born with all the eggs she will ever have. This pool of eggs—called the ovarian reserve—declines over time through a continuous process of follicle loss that accelerates in the years before menopause. After 35, this decline becomes more noticeable in measurable markers, though individual variation is substantial. A woman’s ovarian reserve at 38 tells only part of her fertility story; egg quality, uterine health, and partner fertility are all equally relevant factors.
How Ovarian Reserve Is Assessed
Ovarian reserve is evaluated through a combination of blood tests and ultrasound measurements. No single test gives a complete picture, and results are most meaningful when interpreted together and in the context of a woman’s broader health history.
Anti-Müllerian Hormone (AMH)
AMH is produced by small follicles in the ovary and is currently the most widely used blood marker of ovarian reserve. Unlike FSH, AMH levels are relatively stable across the menstrual cycle and can be tested on any cycle day. Higher AMH levels generally indicate more remaining follicles; lower levels suggest a reduced reserve. According to information reviewed by the National Institute of Child Health and Human Development (NICHD), AMH is a useful marker of ovarian reserve but should not be interpreted in isolation.
Antral Follicle Count (AFC)
An antral follicle count is performed via transvaginal ultrasound, typically in the early follicular phase of the cycle. The clinician counts the small resting follicles visible in both ovaries—these represent the pool of follicles available for that cycle. AFC and AMH are generally well correlated and together provide a more complete picture than either test alone. AFC is also used to predict response to ovarian stimulation if IVF is being considered.
FSH and Estradiol
Follicle-stimulating hormone (FSH) tested on day 2–3 of the menstrual cycle has historically been used as an ovarian reserve marker. Elevated FSH may indicate the pituitary is working harder to stimulate the ovaries, which can be a sign of declining reserve. Estradiol is measured alongside FSH because elevated early-cycle estradiol can falsely normalise FSH levels. FSH testing has largely been supplemented by AMH in many clinical settings, though it remains part of a comprehensive fertility evaluation as covered in our guide to fertility evaluations after 35.
What Ovarian Reserve Results Mean—and Don’t Mean
This is arguably the most important section for women who have received an ovarian reserve test result and are trying to make sense of it. Several common misconceptions are worth addressing directly.
Low AMH or low AFC is a marker of reduced egg quantity—it does not directly measure egg quality or the likelihood of a successful pregnancy. Some women with low AMH conceive naturally; others with normal AMH experience fertility difficulties for unrelated reasons. Reserve markers predict response to ovarian stimulation (relevant for IVF) more reliably than they predict natural conception rates. Interpreting reserve results in isolation, without considering age, cycle regularity, and partner fertility, provides an incomplete picture.
Conversely, a normal or high AMH does not guarantee conception. AMH reflects quantity, not quality. Women with normal reserve can still experience difficulties related to egg quality, implantation, or other factors. This is why reserve testing is best understood as one input into a broader fertility assessment rather than a definitive fertility verdict.
When to Have Ovarian Reserve Testing
For women over 35 who are planning to conceive or are actively trying, ovarian reserve testing is generally considered a worthwhile early step—both to inform timing decisions and to guide conversations about whether assisted reproduction may be beneficial. If reserve is significantly reduced, earlier referral to a reproductive specialist is typically advised rather than waiting the standard six months. If reserve appears adequate, this provides useful reassurance while other fertility factors are assessed.
For women who are not yet ready to conceive but are planning ahead, understanding current reserve levels may help inform decisions about fertility preservation (egg freezing). A reproductive endocrinologist can help contextualise results and discuss whether fertility preservation may be worth considering given your individual circumstances.
Frequently Asked Questions
What is considered a low AMH after 35?
AMH reference ranges vary by laboratory, but values below approximately 1.0–1.2 ng/mL are often described as low for women in their mid-to-late 30s. However, what is “low” also depends on age—an AMH that would be concerning at 30 may be expected at 40. Your healthcare provider can interpret your result in the context of your age and other reserve markers.
Can ovarian reserve be improved?
There are no clinically proven interventions that reliably increase ovarian reserve once it has declined. Some research has explored supplements such as CoQ10 and DHEA in the context of IVF, but evidence for significant effects on reserve markers in natural conception is limited. A reproductive specialist can advise on whether any adjunctive approaches may be relevant to your individual situation.
Does a low AMH mean I can’t get pregnant naturally?
No. Low AMH indicates reduced egg quantity but does not mean natural conception is impossible. Natural conception requires just one good egg per cycle, and women with low AMH can and do conceive naturally. Low reserve may suggest that time is more limited, which is why earlier specialist consultation is recommended—but it is not a definitive barrier to natural pregnancy.
How often should ovarian reserve be tested?
There is no universal recommendation for repeat testing frequency. For women who have had a normal result and are not yet trying to conceive, annual AMH testing provides a general trend over time. For women actively trying or in fertility treatment, testing may be performed more frequently as part of cycle monitoring. Your healthcare provider can advise on what is appropriate for your situation.
Key Takeaways
- Ovarian reserve reflects egg quantity, not quality—low reserve does not mean natural conception is impossible, just that earlier specialist consultation may be beneficial.
- AMH and antral follicle count are the most widely used reserve markers; FSH and estradiol provide additional information when interpreted together.
- Reserve results should be interpreted in the context of age, cycle history, and partner fertility—not in isolation.
- For women over 35, ovarian reserve testing early in the fertility journey can inform timing decisions and specialist referral if needed.
- There are no clinically proven interventions to reliably restore ovarian reserve; a reproductive specialist can advise on whether any adjunctive approaches are relevant to your situation.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.